Doximity (NASDAQ:DOCS) Price Target Raised to $43.00 at Wells Fargo & Company

Doximity (NASDAQ:DOCSFree Report) had its price target boosted by Wells Fargo & Company from $41.00 to $43.00 in a research note published on Monday,Benzinga reports. The firm currently has an equal weight rating on the stock.

Several other analysts have also issued reports on DOCS. Raymond James reissued an “outperform” rating and set a $65.00 price target (up previously from $37.00) on shares of Doximity in a report on Friday, November 8th. Evercore ISI boosted their price target on Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Barclays boosted their price target on Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a report on Monday, November 11th. Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and boosted their price target for the company from $33.00 to $53.00 in a report on Thursday, November 14th. Finally, Baird R W raised Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Thirteen equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $53.12.

Check Out Our Latest Research Report on Doximity

Doximity Stock Performance

Doximity stock opened at $49.50 on Monday. The stock has a fifty day moving average of $53.23 and a 200 day moving average of $41.93. Doximity has a one year low of $22.96 and a one year high of $61.75. The stock has a market cap of $9.24 billion, a PE ratio of 56.90, a price-to-earnings-growth ratio of 4.13 and a beta of 1.40.

Hedge Funds Weigh In On Doximity

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Farther Finance Advisors LLC boosted its stake in Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after buying an additional 603 shares during the last quarter. Morse Asset Management Inc purchased a new stake in Doximity during the third quarter valued at approximately $46,000. GAMMA Investing LLC raised its position in Doximity by 40.1% during the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after purchasing an additional 412 shares during the period. Quarry LP raised its position in Doximity by 101.2% during the second quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after purchasing an additional 131,253 shares during the period. Finally, Covestor Ltd raised its position in Doximity by 441.9% during the third quarter. Covestor Ltd now owns 1,680 shares of the company’s stock valued at $73,000 after purchasing an additional 1,370 shares during the period. 87.19% of the stock is owned by institutional investors.

About Doximity

(Get Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Analyst Recommendations for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.